Budgetary Effects of Policies That Would Increase Hepatitis C Treatment

Congressional Budget Office

No 60237, Reports from Congressional Budget Office

Abstract: CBO describes its initial analysis of the potential federal budgetary effects of policies that would increase treatment of hepatitis C, a liver disease that, left untreated, can lead to serious liver problems. The agency focused on two sample national policies that would increase treatment rates among Medicaid enrollees and thereby affect federal spending on health care.

JEL-codes: I12 I13 I18 I38 (search for similar items in EconPapers)
Date: 2024-06-14
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.cbo.gov/system/files/2024-06/60237-HepatitisC.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cbo:report:60237

Access Statistics for this paper

More papers in Reports from Congressional Budget Office Contact information at EDIRC.
Bibliographic data for series maintained by ().